Influenza A Viruses More Likely To Emerge In East Asia Than North America
News Sep 30, 2015
However, a lack of reporting from many countries--including much of Africa and South America--hinders efforts to fully understand global diversity and determine where the next pandemic influenza virus may emerge.
Many subtypes of influenza A viruses are circulating in people, domestic animals and wild birds throughout the world. In recent years, increasing numbers of influenza A virus subtypes have been found in humans, sometimes with fatal results.
"The world is starting to realize that if you only target certain viruses for testing, you'll miss the new ones that may be circulating," said corresponding author Tracey Goldstein, director of the UC Davis One Health Institute Laboratory.
The One Health Institute leads USAID's PREDICT program, a global project with the goal to rapidly detect and respond to emerging viruses that move among people, wildlife and livestock. For this study the PREDICT team examined the current available data on influenza A viruses to understand where they are emerging and mutating, with the goal of better directing surveillance efforts.
Looking for the overlooked
Rather than focusing on a particular subtype and risk overlooking important emerging types, the scientists analyzed all available subtypes to help prioritize which ones should be examined more closely.
For example, many labs around the world are conducting targeted testing for H1N1 because it caused a pandemic in 2009, or H5N1, an avian flu, because it has serious implications for poultry worldwide, the authors said. But when H7N9, another avian influenza strain, emerged, it caught scientists off guard.
"If we look more broadly to detect all influenza, we'd have a better handle on what might be coming next," Goldstein said.
More data please
The scientists evaluated 14 high priority subtypes of the virus in 32 countries over a 12-year period. While they were able to see a distinctly higher likelihood of new subtypes of influenza A emerging in East Asia than in North America or Europe, underreporting in other countries meant there was not enough data to understand the larger global picture.
"A lot of countries probably have some, if not all, of these subtypes, but we just don't have the data to know," said lead author Daniel Rejmanek, a postdoctoral fellow with the One Health Institute.
"This study points to the need for increased reporting and surveillance worldwide."
Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain TherapeuticsNews
The new Swiss company will operate in Lugano and Barcelona under the scientific management of Minoryx co-founder Dr Xavier Barril.READ MORE
Sequencing Shows How Evolution Can Undermine Bioprocess CommercializationNews
Rapid evolution can suppress the effect of pro-production genes in biochemical processes.READ MORE
Susan Audino Joins CloudLIMS’ Scientific Advisory BoardNews
Dr. Susan Audino, Chair of the Cannabis Working Group at AOAC International, has joined the Scientific Advisory Board at CloudLIMS, which specialises in data management solutions for cannabis testing laboratories.READ MORE
Comments | 0 ADD COMMENT
World Advanced Therapies & Regenerative Medicine Congress
May 16 - May 18, 2018